Health Catalyst (HCAT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Health Catalyst (HCAT) is Neutral.

The composite score behind that read is -0.15, weighing +0.31 of bullish evidence against -0.31 bearish.

Health Catalyst last closed at $1.77, +1.14% on the session.

Against the IVW growth benchmark the position is +0.34% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for HCAT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Health Catalyst in the 8th percentile on return on equity, where 100 is best.

Health Catalyst is classified under Health Care / Health Care Technology, with a market capitalisation of $131.70M.

StockMap tracks Health Catalyst as the 16th largest of the 20 companies it covers in the Health Care Technology industry, part of the Health Care sector.

Across that group the current two-week reads are 14 Neutral, 5 Moderate Underperform and 1 Moderate Outperform.

On that composite Health Catalyst ranks 15th of 20 in the group, against a group median of +0.01.